Pietrock Charlotte, von Haehling Stephan
Division of Cardiology and Metabolism: Heart Failure, Cachexia and Sarcopenia, Department of Internal Medicine and Cardiology, Charité Medical School, Berlin, Germany.
Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany.
ESC Heart Fail. 2017 Aug;4(3):198-202. doi: 10.1002/ehf2.12193. Epub 2017 Jul 17.
Sleep-disordered breathing has a high prevalence in the general population, but is especially prominent in patients with heart failure (HF). HF and sleep-disordered breathing share a bidirectional relationship, with sleep-disordered breathing being both cause and effect of poor cardiac functioning. The high inter-individual variability of symptom presentation can impede the clinical diagnostic process. Polysomnography is the gold-standard method of diagnosing sleep-disordered breathing. Therapy of sleep-disordered breathing should always consist of optimizing the treatment of the underlying disorder of HF. Additional therapeutic measures include continuous positive airway pressure ventilation therapy. New therapeutic options using neurostimulation are yielding promising results; however, long-term benefits still need to be confirmed.
睡眠呼吸障碍在普通人群中具有较高的患病率,但在心力衰竭(HF)患者中尤为突出。HF与睡眠呼吸障碍存在双向关系,睡眠呼吸障碍既是心脏功能不良的原因,也是其结果。症状表现的个体差异较大,这可能会阻碍临床诊断过程。多导睡眠图是诊断睡眠呼吸障碍的金标准方法。睡眠呼吸障碍的治疗应始终包括优化HF基础疾病的治疗。额外的治疗措施包括持续气道正压通气治疗。使用神经刺激的新治疗选择正在产生有希望的结果;然而,长期益处仍需得到证实。